The inhibition of mTOR promotes redifferentiation of thyroid cancer cells by upregulating NIS mRNA and protein expression, resulting in elevated iodine uptake through increased transcription at the level of thyroid transcription factor-1 (TTF1), which indicates TTF1 dependence for NIS expression [62,63]. This evidence concerns the gene SLC5A5 and thyroid gland carcinoma.